From Appleby

Appleby has acted as Cayman counsel for PW Medtech Group in relation to its listing on the Main Board of the Hong Kong Stock Exchange on 8 November 2013, with net proceeds of approximately HKD1.4bn (approximately $188m), including the proceeds from the over-allotment of shares. The offering was 19.33 times oversubscribed.

The Appleby team was led by John Melia, a corporate and commercial partner in Appleby’s Hong Kong office, assisted by associates Vincent Chan and Jo Lit.

Chen & Associates and Wilson Sonsini Goodrich & Rosati advised the company as to Hong Kong and US law, while Clifford Chance advised the underwriters as to Hong Kong and US law.

AND

Appleby acts as Bermuda and BVI counsel to Credit Suisse on convertible bond issuance

Appleby has acted as both Bermuda and British Virgin Islands (BVI) counsel to Credit Suisse Singapore Branch in connection with a two-tranche ($50m and further $70m) convertible bond issuance by Bermuda-incorporated Hong Kong-listed Goldpoly New Energy Holdings.

Credit Suisse acted as arranger and one of the purchasers of the bonds.

The bonds were guaranteed and secured by various Hong Kong and BVI subsidiaries of Goldpoly. Appleby provided Bermuda and BVI advice to Credit Suisse in relation to the bond issuance and the granting of security by the BVI subsidiaries of Goldpoly.

The Appleby team consisted of partner Jeffrey Kirk and senior associate Rupen Shah.